Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Cancer Chemotherapy and Pharmacology
|
March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
Hernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2014
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts
Santi Suryani, Hernan Carol, Triona Ni Chonghaile, et al.
Molecular Cancer Therapeutics
|
December 16, 2014
Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia
Santi Suryani, Lauryn S Bracken, Richard C Harvey, et al.
Pediatric Blood & Cancer
|
October 27, 2006
The pediatric preclinical testing program: description of models and early testing results
Peter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Cancer Chemotherapy and Pharmacology
|
March 31, 2011
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer
Hernan Carol, Ingrid Boehm, C Patrick Reynolds, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2014
Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts
Santi Suryani, Hernan Carol, Triona Ni Chonghaile, et al.
Molecular Cancer Therapeutics
|
December 16, 2014
Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia
Santi Suryani, Lauryn S Bracken, Richard C Harvey, et al.
Pediatric Blood & Cancer
|
October 27, 2006
The pediatric preclinical testing program: description of models and early testing results
Peter J Houghton, Christopher L Morton, Chandra Tucker, et al.
Page
of 7